Moderna (MRNA) Capital Expenditures Growth (3y) (2021 - 2026)
Moderna (MRNA) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moderna | 21.94 Bn | 16.73 Bn | -566.00 Mn | -32.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.34% |
| Dec 31, 2025 | -24.88% |
| Sep 30, 2025 | 6.00% |
| Jun 30, 2025 | -34.84% |
| Mar 31, 2025 | 22.27% |
| Dec 31, 2024 | -24.98% |
| Sep 30, 2024 | -570.92% |
| Jun 30, 2024 | 60.52% |
| Mar 31, 2024 | 110.55% |
| Dec 31, 2023 | 116.61% |
| Sep 30, 2023 | 120.70% |
| Jun 30, 2023 | -81.71% |
| Mar 31, 2023 | 152.73% |
| Dec 31, 2022 | 87.81% |
| Sep 30, 2022 | 67.86% |
| Jun 30, 2022 | 370.13% |
| Mar 31, 2022 | 103.49% |
| Dec 31, 2021 | -21.49% |
| Sep 30, 2021 | 27.34% |
| Jun 30, 2021 | 405.50% |